Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ESMO Targeted Anticancer Therapies Congress 2021

Start date
01 Mar 2021
End date
03 Mar 2021
Paris, France

The ESMO Targeted Anticancer Therapies Congress 2021 will give you a glimpse of the future of targeted anticancer therapies, as the premier international meeting focusing on promising new anticancer targets and agents, with a particular focus on those in early phase clinical development.

TAT 2021 will also offer excellent opportunities for the presentation and discussion of ongoing and completed phase 1 studies in a highly interactive setting.

The current programme provides reviews and reports of recent research findings on a broad range of molecular targets and targeted anticancer agents.

Stakeholders from academy and industry will meet with clinicians, researchers and regulators to enhance the global dissemination of knowledge and clinical research expertise in the field of innovative cancer therapeutics, to the benefit of cancer patients worldwide.


ESMO Head Office
Via Ginevra 4
6900 Lugano



Access the programme of the ESMO Targeted Anticancer Therapies Congress 2021



The abstract submission for TAT 2021 is now open!

TAT map block image

Map & Venue

View the congress location on an interactive map



Get in touch with the organisers of the ESMO Targeted Anticancer Therapies Congress 2021. You'll find the contact details here

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings